{{Rsnum
|rsid=7141276
|Chromosome=14
|position=34665980
|Orientation=plus
|GMAF=0.4692
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 45.1 | 38.1 | 16.8
| HCB | 23.7 | 45.2 | 31.1
| JPT | 13.3 | 47.8 | 38.9
| YRI | 4.1 | 40.8 | 55.1
| ASW | 8.8 | 47.4 | 43.9
| CHB | 23.7 | 45.2 | 31.1
| CHD | 15.0 | 44.9 | 40.2
| GIH | 41.6 | 53.5 | 5.0
| LWK | 9.2 | 43.1 | 47.7
| MEX | 20.7 | 48.3 | 31.0
| MKK | 12.2 | 37.8 | 50.0
| TSI | 36.3 | 50.0 | 13.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23555300
  |Trait=Response to anti-TNF treatment in rheumatoid arthritis
  |Title=Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.
  |RiskAllele=A
  |Pval=2E-6
  |OR=.37
  |ORtxt=[NR] unit increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}